Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
April 5, 2004
- Iryo Proverbs Reveal Japanese Spirit (18)
April 5, 2004
- Janssen Pharmaceutical Aims at Sales of \100 Bil. in 2006: Mr Sekiguchi
April 5, 2004
- DIAGNOSTIC NEWS IN BRIEF
April 5, 2004
- CORPORATE ROUNDUP NEWS IN BRIEF
April 5, 2004
- Kyowa Hakko to License "Potelligent" Technology to US Companies
April 5, 2004
- Somusho Asks Korosho to Simplify Approval Modification Procedure
April 5, 2004
- BULLETIN
April 5, 2004
- Off-label Use of Drugs in Children Reported: Korosho Panel
April 5, 2004
- REGULATORY NEWS IN BRIEF
April 5, 2004
- Generics' Share Up to 6.3% on Purchase Price Basis at National Hospitals
April 5, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 5, 2004
- AS-3201 Shows Promise for Diabetic Neuropathy: Dainippon
April 5, 2004
- Merger Synergism Boosts Chugai's Performances: Mr Nagayama
April 5, 2004
- Gastric Cancer Therapeutic GL to Be Revised
April 5, 2004
- WORLD NEWS IN BRIEF
April 5, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
April 5, 2004
- Asahi Kasei Pharma to Promote Elcitonin for Pain in Osteoporosis
April 5, 2004
- BULLETIN
April 5, 2004
- Midterm Management Plan for Mediceo Group Announced
April 5, 2004
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…